Amrize Reports First Independent Quarter but Analysts Expect Separation Costs to Eclipse Revenue Growth

Amrize Ltd (AMRZ) reports first-quarter fiscal 2026 earnings after market close on April 29, 2026, with Wall Street bracing for the company's first quarterly loss in recent memory. The consensus estimate calls for an EPS of -$0.14, a dramatic reversal from profitability in prior quarters, raising questions about whether recent operational headwinds are temporary or signal deeper structural challenges. With analyst sentiment holding steady but technical momentum strengthening sharply in recent weeks, investors face a critical test of confidence in management's turnaround narrative.

Part 1: Earnings Preview

Amrize Ltd operates as a diversified building products manufacturer, supplying construction materials and specialty products across residential and commercial markets in North America. The company's portfolio spans cement, aggregates, ready-mix concrete, and asphalt, positioning it as a key supplier to infrastructure and housing development projects.

AMRZ is expected to report first-quarter results after the close on April 29, 2026. The consensus estimate from 3 analysts calls for an EPS of -$0.14, with estimates ranging from -$0.15 to -$0.12. The company most recently reported fourth-quarter fiscal 2025 EPS of $0.62 on February 17, 2026, beating the $0.59 estimate by 5.08%. Year-over-year comparisons are unavailable as the company did not report results for the first quarter of fiscal 2025, making this a particularly uncertain release for investors trying to gauge underlying business trends.

Three key themes define this earnings story:

Seasonal Weakness and Weather Impact: The first quarter historically represents the weakest period for building products companies due to winter weather disruptions and reduced construction activity. Investors will scrutinize whether the expected loss reflects normal seasonality or points to deteriorating demand conditions that could persist into the spring building season.

Margin Pressure and Cost Management: With revenue growth estimates pointing to a 24% rebound expected in the second quarter, the focus shifts to whether AMRZ can translate top-line recovery into profitability. Analysts are watching for commentary on raw material costs, pricing power, and operational efficiency initiatives that could support margin expansion as volumes recover.

Full-Year Guidance and Demand Outlook: The consensus projects full-year fiscal 2026 EPS of $2.76, implying 15% growth from fiscal 2025's $2.40. Management's outlook for residential and infrastructure spending, along with any updates on backlog and project pipelines, will be critical in validating whether the Street's growth expectations remain achievable despite the weak start to the year.

Analyst commentary ahead of the release reflects cautious optimism tempered by near-term uncertainty. The 11 Strong Buy ratings and average price target of $66.06 suggest confidence in the longer-term story, but the wide range of estimates for the current quarter—spanning from -$0.15 to -$0.12—underscores the difficulty in modeling seasonal volatility and operational execution during a transitional period for the business.

Part 2: Historical Earnings Performance

AMRZ's recent earnings track record reveals a company struggling to meet Wall Street's expectations, with two of the last three quarters delivering significant misses. In Q2 fiscal 2025 (June quarter), the company reported EPS of $0.78 against an estimate of $1.03, a substantial -24.27% miss that raised concerns about demand softness and operational challenges. The company rebounded in Q3 fiscal 2025 (September quarter) with EPS of $1.06 versus the $1.01 estimate, a modest +4.95% beat, followed by another small beat in Q4 fiscal 2025 (December quarter) with $0.62 against $0.59, a +5.08% surprise.

The pattern suggests AMRZ has stabilized after the sharp Q2 miss, delivering back-to-back modest beats in the second half of fiscal 2025. However, the magnitude of those beats—averaging around 5%—pales in comparison to the severity of the June quarter shortfall, leaving the company with ground to make up in rebuilding credibility with investors. The upcoming first-quarter report, with its expected loss, will test whether management has truly turned the corner or whether the recent beats simply reflected easier comparisons and seasonal tailwinds that are now reversing.

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

AMRZ reports after market close, meaning Day 0 captures anticipatory trading before results are released, while Day +1 reflects the market's first full session to digest the actual numbers.

Historical price action around earnings shows AMRZ is a high-volatility stock that delivers dramatic post-earnings moves. The average absolute Day +1 move stands at 7.50%, with the most recent February 2026 report producing a +10.99% surge despite the company missing estimates—suggesting investors focused on forward guidance or relief that results weren't worse. The October 2025 report saw a more modest +4.78% gain following a beat, while the August 2025 miss triggered a sharp -6.72% decline.

The Day 0 moves average just 1.31%, indicating limited anticipatory positioning, but the Day +1 range of 6.72% confirms that the real action happens once results are public. Investors should prepare for significant volatility, with historical precedent suggesting moves in the 5–11% range are entirely normal for AMRZ earnings events, regardless of whether the company beats or misses estimates.

Part 2.2: Options Market Expected Move

The options market is pricing an expected move of 3.70% (±$2.13) through the May 15 expiration, which is significantly below the stock's average historical Day +1 earnings move of 7.50%. This suggests options traders may be underestimating potential volatility, creating possible opportunities for strategies that benefit from larger-than-expected price swings. The 49.80% average implied volatility reflects elevated uncertainty, but the muted expected move relative to historical performance indicates the market may not be fully pricing in AMRZ's tendency to deliver outsized reactions to quarterly results.

Part 3: What Analysts Are Saying

Analyst sentiment on AMRZ remains solidly bullish, with a consensus rating of 4.15 out of 5.0 and an average price target of $66.06—implying 14.9% upside from the current price of $57.47. The rating breakdown shows strong conviction, with 11 Strong Buy ratings and 1 Moderate Buy among the 20 analysts covering the stock, while 8 analysts maintain Hold ratings and none recommend selling. The price target range spans from a low of $43.00 to a high of $76.00, reflecting divergent views on the company's ability to navigate near-term challenges while capturing longer-term growth opportunities.

Sentiment has remained unchanged over the past month, with rating counts and the average recommendation holding steady at 4.15. This stability suggests analysts are maintaining their positions heading into the first-quarter report, neither upgrading in anticipation of a positive surprise nor downgrading due to concerns about the expected loss. The lack of recent revisions indicates the Street is largely waiting for management's commentary and guidance before making significant changes to models or recommendations.

The consensus price target of $66.06 implies analysts see the current weakness as temporary, with the stock trading at a meaningful discount to fair value. However, the wide dispersion in targets—a 77% spread between the high and low estimates—highlights the uncertainty surrounding AMRZ's earnings trajectory and the difficulty in modeling a business exposed to cyclical construction markets and seasonal volatility. The upcoming earnings report will be critical in determining whether the bullish consensus remains intact or whether analysts begin to reassess their optimistic stance in light of the first-quarter loss and any cautious guidance from management.

Part 4: Technical Picture

AMRZ enters earnings with rapidly improving technical momentum, as the Barchart Technical Opinion has surged to a 64% Buy signal from just 8% Sell a month ago and 48% Buy a week ago. This sharp reversal reflects strengthening price action and positive indicator readings heading into the April 29 report, suggesting the stock has built constructive momentum despite the challenging fundamental backdrop.

Timeframe Analysis:

• Short-term (50% Buy): Moderate buy signal indicates near-term momentum is positive but not yet at extreme levels, leaving room for further upside if earnings deliver positive surprises
• Medium-term (50% Buy): Matching the short-term reading, the intermediate timeframe shows balanced momentum without signs of overextension or exhaustion
• Long-term (100% Buy): Strong buy signal confirms the longer-term trend remains firmly positive, providing a supportive backdrop for investors willing to look past near-term volatility

Trend Characteristics: The trend is rated as Good strength but Weakening direction, suggesting that while the overall technical environment remains supportive, recent momentum has begun to fade slightly—a nuanced setup that could go either way depending on earnings results and guidance.

The stock is trading at $57.47, positioned above its 5-day ($57.33), 20-day ($57.04), 100-day ($56.78), and 200-day ($53.54) moving averages, but below its 10-day ($57.56) and 50-day ($58.25) averages.

The technical setup is cautiously supportive heading into earnings, with the stock holding above key longer-term moving averages and the 200-day trend line providing a solid foundation near $53.54. However, the failure to reclaim the 50-day average at $58.25 suggests some near-term resistance, and the slight pullback from the 10-day average indicates consolidation rather than aggressive buying. The sharp improvement in the Barchart Opinion signal over the past month reflects positive momentum, but the "Weakening" direction component warns that follow-through has been inconsistent. For bulls, a strong earnings report and upbeat guidance could propel the stock through the $58–$59 resistance zone; for bears, a disappointing outlook could quickly test support at the 100-day average near $56.78 or even the 200-day line if selling accelerates.